SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study

Symptomatic Cervical Disc Disease Clinical Trial

Official title:
A Prospective Randomized Clinical Investigation of the SECURE-C Cervical Artificial Disc: A Pivotal Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study

Status Completed

Clinical Trial Summary

The purpose of the pivotal IDE clinical study was to evaluate the safety and effectiveness of the SECURE®-C Cervical Artificial Disc for the treatment of symptomatic cervical disc disease at one level between C3 and C7, compared to anterior cervical discectomy and fusion.

The purpose of the Postmarket Approval Study is to evaluate the long-term safety and efficacy associated with the use of the SECURE-C Cervical Artificial Disc

Clinical Trial Description

Ages Eligible for Study: 18 to 60 years

Genders Eligible for Study: Both

Accepts Healthy Volunteers: No ;

Study Design

Related Conditions & MeSH terms

Symptomatic Cervical Disc Disease

Clinical Trial Details

NCT number	NCT00882661
Study type	Interventional
Source	Globus Medical Inc
Contact
Status	Completed
Phase	N/A
Start date	July 2005
Completion date	February 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00758758` - Performance of the Hedrocel(R) Cervical Fusion Device	Phase 3
Not yet recruiting	`NCT04167878` - Exploratory Study of 3D Printed Biodegradable Cervical Interbody Fusion Cage	N/A
Recruiting	`NCT04012996` - 2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C	N/A
Completed	`NCT00291018` - Safety and Efficacy Study Comparing ProDisc-C to ACDF Surgery to Treat SCDD	N/A
Not yet recruiting	`NCT05610397` - Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels
Terminated	`NCT03828136` - Novum Vitrium® Cervical Cage in Anterior Cervical Discectomy and Fusion	N/A